Sitemap
Medical science
03/2003 Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial
03/2003 Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project
03/2003 Age at first treatment and immune tolerance to factor VIII in severe hemophilia
03/2003 A quantitative measure of the efficacy of factor VIII in hemophilia A mice
03/2003 Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction
03/2003 Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use
03/2003 Travel and the risk of symptomatic venous thromboembolism
03/2003 Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome
03/2003 CD32-dependent platelet activation by a drug-dependent antibody to glycoprotein IIb/IIIa antagonists
03/2003 Focusing on transcription factor families in atherogenesis: the function of LKLF and TR3
03/2003 Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase
03/2003 Vascular thrombogenicity induced by progressive LDL oxidation: protection by antioxidants
03/2003 Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence
03/2003 Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis
03/2003 Fibrin-based biomaterials to deliver human growth factors
03/2003 2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves
03/2003 Platelet Receptors and Their Role in Diseases
03/2003 Real-Time RT-PCR for the Measurement of Prostate-Specific Antigen mRNA Expression in Benign
Hyperplasia and Adenocarcinoma of Prostate
03/2003 Detection of a Novel Exon 4 Low-Density
Lipoprotein Receptor Gene Deletion in a
Swiss Family with Severe Familial
Hypercholesterolemia
03/2003 Absence of Known Familial Hemiplegic Migraine
(FHM) Mutations in the CACNA1A Gene in
Patients with common Migraine: Implications for
Genetic Testing
03/2003 Association between 5,10-Methylenetetrahydrofolate
Reductase C677T and A1298C Polymorphisms and
Conotruncal Heart Defects
03/2003 Rapid and Reliable Genotyping of the C181T
Polymorphism in the Bradykinin B2 Receptor
Gene
03/2003 Steroids, Sex Hormone-Binding Globulin,
Homocysteine, Selected Hormones and
Markers of Lipid and Carbohydrate Metabolism
in Patients with Severe Hypothyroidism and
Their Changes Following Thyroid Hormone
Supplementation
03/2003 Anaerobic Bacteremia: The Yield of Positive
Anaerobic Blood Cultures: Patient Characteristics
and Potential Risk Factors
03/2003 Genotyping of Alcohol Dehydrogenase Type 2
and 3 Using a Two-Buffer Polyacrylamide Gel
Electrophoresis System
03/2003 Effect of Partial Proteolysis on the Activation
Energy of ?-N-Acetylhexosaminidase Precursor
and Mature Forms
03/2003 Angiogenin and Gestational Trophoblastic Tumors,
a Promising Prognostic Marker
03/2003 Carbohydrate 19-9 Antigen Is Not a Marker of
Liver Disease in Patients with Cystic Fibrosis
03/2003 Assay Using Succinyldithiocholine as Substrate:
The Method of Choice for the Measurement of
Cholinesterase Catalytic Activity in Serum to
Diagnose Succinyldicholine Sensitivity
03/2003 National External Quality Assessment Scheme
for Lymphocyte Immunophenotyping in
Belgium
03/2003 Quality Assurance for Cerebrospinal Fluid
Protein Analysis: International Consensus by an
Internet-Based Group Discussion
03/2003 Guidelines for the Analysis of Bence Jones
Protein
03/2003 Discordance Rate, a New Concept for Combining
Diagnostic Decisions with Analytical Performance
Characteristics. 1. Application in Method or
Sample System Comparisons and in Defining
Decision Limits
03/2003 Urinary Homogentisic Acid in Alkaptonuric and
Healthy Children
03/2003 The Influence of Hemolysis, Turbidity and Icterus
on the Measurements of CK-MB, Troponin I and
Myoglobin
03/2003 Evaluation of Cobas IntegraŽ 800 under Simulated
Routine Conditions in Six Laboratories
03/2003 Guidelines for the Laboratory Investigation of
Inherited Thrombophilias. Recommendations
for the First Level Clinical Laboratories
03/2003 Mode of conception, placental morphology and perinatal outcome of twin
gestations
03/2003 The effects of birth weight discordance and prematurity on twin neonatal
outcome
03/2003 Esophageal atresia and tracheoesophageal fistula: the impact of prenatal
suspicion on neonatal outcome in a tertiary care center
03/2003 Microbial invasion of the amniotic cavity at birth is associated with adverse
short-term outcome of preterm infants
03/2003 Is treatment with vaginal pessaries an option in patients with a sonographically
detected short cervix?
03/2003 The effects of intramuscular administration of corticosteroids on the
induction of parturition
03/2003 Perinatal significance of diagnosing glucose intolerance during pregnancy
with portable glucose meter
03/2003 Biovar diversity of Ureaplasma urealyticum in amniotic fluid: distribution,
intrauterine inflammatory response and pregnancy outcomes
03/2003 Comparative study on the expression of cytokine – receptor genes in normal
and preeclamptic human placentas using DNA microarrays
03/2003 Chorioangioma – new insights into a well-known problem
I. Results of a clinical and morphological study of 136 cases
03/2003 Chorioangiomas – new insights into a well-known problem
II. An immuno-histochemical investigation of 136 cases
03/2003 Impaired CD14-dependent and independent response of polymorphonuclear
leukocytes in preterm infants
03/2003 The left portal vein is the watershed of the fetal venous system
04/2003 Fibrin(ogen) in cardiovascular disease: an update
04/2003 Molecular and cellular modulation of fibrinolysis
04/2003 The ADAMs family of proteins: from basic studies to potential clinical applications
04/2003 Protofibrils within fibrin fibres are packed together in a regular array
04/2003 New molecular defects in the subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover VI, Homburg VII, Stuttgart and Suhl
04/2003 V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site
04/2003 Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases
04/2003 Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases
04/2003 Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis
04/2003 Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease
04/2003 Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients
04/2003 Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation
04/2003 Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer
04/2003 Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma
04/2003 Systemic coagulation reactivation in recurrence of colorectal cancer
04/2003 The protective effect of angiotensin converting enzyme inhibition in experimental renal fibrosis in mice is not mediated by bradykinin B2 receptor activation
04/2003 Helicobacter pylori causes gastrointestinal hemorrhage in patients with congenital bleeding disorders
04/2003 Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling
04/2003 Changes in tissue factor and activated factor XII following an acute myocardial infarction were uninfluenced by high doses of n-3 polyunsaturated fatty acids
04/2003 Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment
Back
Search
